Home | Contact Us | Site Map
Molluscum contagiosum

Development

The NanoStat™ candidate for Molluscum contagiosum has been shown to kill smallpox virus in vitro and has been safely used in adults with herpes labialis and onychomycosis. NanoBio plans to initiate a Phase 2 clinical study in Molluscum contagiosum.

About Molluscum contagiosum

Molluscum contagiosum is a common contagious disease caused by a member of the pox virus family.  It is a viral skin infection that causes raised, pearl-like papules or nodules on the skin that is most primarily observed in young children. The virus is spread by physical contact with either the infected person or by contaminated objects such as towels, clothing, or toys. Increasingly, the disease is also observed in adults where the primary route of transmission is attributed to sexual contact. There is no FDA approved treatment for Molluscum contagiosum.

The lesions are frequently seen on the face, neck, armpit, trunk, arms, and hands but may occur anywhere on the body and through sexual transmission, the lower abdomen and genitals. Persons with a weakened immune system may have extensive widespread lesions.


Individual lesions may be removed surgically, by curettage, de-coring, freezing, or through needle electrosurgery. Surgical removal may result in scarring.

BlueLine

© NanoBio® Corporation 2010
NanoBio is a registered trademark of NanoBio Corporation.
All other company, brand, and product names are or may be trademarks of their respective holders. Website by Mellon & Associates, LLC.